Physician
Imtiaz A. Malik, M.D. INC.
Imtiaz A. Malik, M.D. INC. was paid $109K by Medicaid between Jan 2018 and Mar 2019, across 10 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 67% of everything it billed.
33Billing provider infoIMTIAZ A. MALIK, M.D. INC.
MERCED, CA 95340
MERCED, CA 95340
33aNPI1215216809assigned 08/12/2011
33bProvider typeHematology & Oncology Physician
28Total paid$109K
24GClaims2,372
24DCodes billed10
24AFirst – last monthJan 2018 – Mar 2019
Compared with peers
Next to other Hematology & Oncology Physician providers in California
Rank by total paid#53 of 180
Median peer was paid$26K
This provider vs. median4.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,954 | $90K | |
| 2019 | 418 | $19K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 67% | 745 | 697 | $73K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 13% | 248 | 174 | $14K |
| 96367 | 8.8% | 221 | 124 | $10K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 4.9% | 152 | 101 | $5K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.0% | 29 | 13 | $2K |
| J7050 | Infusion, normal saline solution, 250 cc | 1.3% | 423 | 248 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 301 | 181 | $1K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 44 | 27 | $956.39 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 187 | 108 | $693.60 |
| J1750 | Injection, iron dextran, 50 mg | <1% | 22 | 15 | $413.88 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMALIK, IMTIAZ (CEO)